A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients

Celebrating a significant achievement in NAD+ research, these findings contribute to the mounting evidence indicating that NR may serve as a proactive safeguard against inflammatory cytokines in...

Related Keywords

South Korea ,Han ,Tru Niagen ,Blood Institute ,Nasdaq ,Chromadex External Research Program ,Chromadex Corp ,Young ,National Institutes Of Health ,National Heart ,Nicotinamide Adenine Dinucleotide ,Cell Reports ,Michael Sack ,Senior Investigator ,Mitochondrial Biology ,National Institutes ,Rob Fried ,Looking Statements ,Securities Act ,Exchange Act ,Annual Report ,Quarterly Reports ,Markets ,